Judson Althoff, a 12-year veteran of Microsoft, was just named CEO of its commercial business under a leadership restructuring designed to free up Microsoft CEO Satya Nadella to focus more on the ...

Novartis AG (NYSE:NVS) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 24, Novartis AG (NYSE:NVS) announced that new data on Kesimpta for relapsing multiple ...

Two weeks after releasing the first batch of Untitled Letters as part of the Trump administration’s ongoing crackdown on DTC pharma ads, the Food and Drug Administration has released yet another. In a ...

In this article, we will look at the 11 Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 25, Stephen Parker, JPMorgan Private Bank’s co-head of global investment strategy, ...

Novartis has presented new data from two clinical trials that further support the use of Kesimpta (ofatumumab) in the treatment of relapsing multiple sclerosis (RMS). Kesimpta, a self-administered, ...

A large multi-use commercial building caught fire Wednesday morning in Rancho Cordova, the Sacramento Metropolitan Fire District said. Fire crews were dispatched around 7:24 a.m. to a property on ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

Swiss pharma Novartis (NOVN: VX) has unveiled fresh results for Kesimpta (ofatumumab) in relapsing multiple sclerosis, with findings presented at the ECTRIMS 2025 meeting in Barcelona. Two studies ...